生物活性 | |||
---|---|---|---|
描述 | Omecamtiv mecarbil at 10 μM reduces the maximum rate of ATP hydrolysis (kcat) by 4.5-fold and lowers the actin concentration needed for half-maximal ATPase activity (KATPase) by 30-fold. The EC50 of Omecamtiv mecarbil-induced inhibition of actin-activated ATPase is determined to be 0.52 ± 0.10 μM. It does not alter overall actin affinity but causes a state of weak actin affinity in a subset of myosin heads with slow product release. In an in vitro motility assay, it reduces the actin sliding velocity by more than 100-fold[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.49mL 0.50mL 0.25mL |
12.46mL 2.49mL 1.25mL |
24.91mL 4.98mL 2.49mL |
参考文献 |
---|